Deutsche Bank’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1
Closed 5771
2017
Q4
$0 Hold
1
﹤0.01% 5274
2017
Q3
$0 Hold
1
﹤0.01% 5244
2017
Q2
$0 Hold
1
﹤0.01% 5264
2017
Q1
$0 Sell
1
-85
-99% -$738 ﹤0.01% 5241
2016
Q4
$0 Buy
86
+85
+8,500% +$972 ﹤0.01% 5193
2016
Q3
$0 Buy
+1
New +$15 ﹤0.01% 5400

Other funds holding MBVX

Deutsche Bank's MBVX Position: Q1 2018 in Review

Deutsche Bank sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q1 2018, closing a stake of 1 share.

Deutsche Bank first reported a position in MBVX in Q3 2016 and held it in 6 quarters. The position peaked at $0 in Q4 2017. 11 funds tracked by Wall St. Rank hold MBVX as of Q1 2018.

  • Deutsche Bank reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q1 2018 after selling out during the quarter.
  • Deutsche Bank sold 1 MABVAX THERAPEUTICS HLDGS INC share in Q1 2018.
  • Deutsche Bank first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q3 2016 and held it in 6 quarters.
  • Deutsche Bank's MABVAX THERAPEUTICS HLDGS INC position peaked at $0 in Q4 2017.
  • 11 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.